Publications by authors named "Lokman Hızmalı"

4 Publications

  • Page 1 of 1

Evaluation of Nasopharyngeal and Conjunctival Swab Samples of Hospitalised Patients with Confirmed COVID-19.

Ocul Immunol Inflamm 2021 Mar 4:1-4. Epub 2021 Mar 4.

Department of Emergency Medicine, Kırşehir Ahi Evran University School of Medicine, Kırşehir, Turkey.

Purpose: To evaluate the results of conjunctival and nasopharyngeal swab tests in patients with confirmed COVID-19.

Methods: This prospective study included 45 patients who were hospitalized for confirmed COVID-19. Nasopharyngeal swab samples were obtained from the patients before hospitalization. Only one eye of each patient was randomly selected for-conjunctival sampling. All participants underwent a complete slit-lamp examination. Conjunctival and nasopharyngeal swab samples were analyzed by reversetranscriptase-polymerase-chain reaction (RT-PCR).

Results: Twenty seven (60%) of the patients were male and 18 (40%) were female. Conjunctival swab was positive in only one (2.22%) patient. None of the COVID-19 patients showed ocular changes and symptoms. There were no abnormalities of the ocular surface, anterior chamber or posterior segment at slit-lamp examination.

Conclusions: The RT-PCR was not high positive in the conjunctiva as in nasopharyngeal swabs. Ocular changes were not common in COVID-19 patients.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2020.1838558DOI Listing
March 2021

Retinal Vessel Diameter Changes in COVID-19 Infected Patients.

Ocul Immunol Inflamm 2021 Jan 26:1-7. Epub 2021 Jan 26.

Department of Medical Microbiology, Amasya University School of Medicine, Amasya, Turkey.

: To evaluate the longitudinal changes in retinal vessel diameters in patients with coronavirus disease 2019 (COVID-19).: This study included 25 patients with COVID-19 (Group 1) and 25 healthy subjects (Group 2). The diameters of peripapillary temporal and nasal retinal arteries and veins were measured at baseline and at 4 months after remission.: The baseline diameters of the inferior temporal vein and the artery were increased in group 1 compared to controls ( = .007 and = .041, respectively). There was also an increase in the diameters of the inferior and superior nasal veins and arteries in group 1 at baseline ( = .001, = .019, = .037, and = .008, respectively). Retinal vessel diameters decreased after remission in all quadrants in comparison to baseline measurements (all < .05).: Increased retinal vessel diameters were measured in COVID-19 patients during the disease. Measurement of retinal vessel diameters may be a noninvasive method of estimating the vascular risk.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/09273948.2020.1853783DOI Listing
January 2021

Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group.

Turk Gogus Kalp Damar Cerrahisi Derg 2020 Jan 23;28(1):2-42. Epub 2020 Jan 23.

Infective Endocarditis and Other Cardiovascular Infections Study Group.

Infective endocarditis (IE) is rare, but associated with significant morbidity and mortality rates. Estimates of the incidence of IE in Turkey are compromised by the absence of population-based prospective studies. Due to the frequent presence of predisposing cardiac conditions and higher rates of nosocomial bacteremia in highrisk groups, the incidence of IE is expected to be higher in Turkey. Additionally, while IE generally affects older people in developed countries, it still affects young people in Turkey. In order to reduce the mortality and morbidity, it is critical to diagnose the IE to determine the causative agent and to start treatment rapidly. However, most of the patients cannot be diagnosed in their first visits, about half of them can be diagnosed after three months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of identification of causative organisms is significantly lower in Turkey than in developed countries. Furthermore, most of the centers do not perform some essential microbiological diagnostic tests as a routine practice. Some antimicrobials that are recommended as the first-line of treatment for IE, particularly antistaphylococcal penicillins, are not available in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. Physicians can follow patients with IE in many specialties. Diagnosis and treatment processes of IE should be standardized at every stage so that management of IE, a setting in which many physicians are involved, can always be in line with current recommendations. Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases has called for collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the light of current information and local data in Turkey.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.5606/tgkdc.dergisi.2020.01954DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067027PMC
January 2020

Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019.

Turk Kardiyol Dern Ars 2020 03;48(2):187-226

Turkish Society of Clinical Microbiology and Infectious Diseases, Infective Endocarditis and Other Cardiovascular Infections Study Grup (Istanbul University, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Resarch Hospital, Başkent University, İstanbul Medeniyet University, Ankara University, Kartal Koşuyolu High Speciality Training and Research Hospital, Kırşehir Ahi Evran University, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Bezmiâlem Vakıf University, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Resarch Hospital, Ankara City Hospital, Marmara University, Uludağ University, Yozgat Bozok University, Göztepe Training and Research Hospital), İstanbul, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.5543/tkda.2020.89689DOI Listing
March 2020